nodes	percent_of_prediction	percent_of_DWPC	metapath
Aminoglutethimide—CYP11A1—Dexamethasone—psoriatic arthritis	0.289	0.311	CbGbCtD
Aminoglutethimide—CYP19A1—Betamethasone—psoriatic arthritis	0.231	0.249	CbGbCtD
Aminoglutethimide—CYP19A1—Dexamethasone—psoriatic arthritis	0.134	0.145	CbGbCtD
Aminoglutethimide—CYP2C19—Prednisone—psoriatic arthritis	0.0564	0.0608	CbGbCtD
Aminoglutethimide—CYP3A4—Methylprednisolone—psoriatic arthritis	0.045	0.0485	CbGbCtD
Aminoglutethimide—CYP2C19—Dexamethasone—psoriatic arthritis	0.0352	0.038	CbGbCtD
Aminoglutethimide—CYP3A4—Triamcinolone—psoriatic arthritis	0.0341	0.0368	CbGbCtD
Aminoglutethimide—CYP3A4—Betamethasone—psoriatic arthritis	0.0293	0.0316	CbGbCtD
Aminoglutethimide—CYP3A4—Prednisolone—psoriatic arthritis	0.0289	0.0311	CbGbCtD
Aminoglutethimide—CYP3A4—Prednisone—psoriatic arthritis	0.0273	0.0294	CbGbCtD
Aminoglutethimide—CYP3A4—Dexamethasone—psoriatic arthritis	0.017	0.0184	CbGbCtD
Aminoglutethimide—Adrenal insufficiency—Prednisone—psoriatic arthritis	0.0045	0.0615	CcSEcCtD
Aminoglutethimide—Alveolitis allergic—Methotrexate—psoriatic arthritis	0.00302	0.0413	CcSEcCtD
Aminoglutethimide—Pancytopenia—Auranofin—psoriatic arthritis	0.00242	0.0331	CcSEcCtD
Aminoglutethimide—Neutropenia—Auranofin—psoriatic arthritis	0.00239	0.0326	CcSEcCtD
Aminoglutethimide—Hirsutism—Prednisolone—psoriatic arthritis	0.00223	0.0305	CcSEcCtD
Aminoglutethimide—Agranulocytosis—Auranofin—psoriatic arthritis	0.00212	0.029	CcSEcCtD
Aminoglutethimide—Haematocrit decreased—Methotrexate—psoriatic arthritis	0.00211	0.0289	CcSEcCtD
Aminoglutethimide—Hirsutism—Triamcinolone—psoriatic arthritis	0.00205	0.0281	CcSEcCtD
Aminoglutethimide—Hirsutism—Methylprednisolone—psoriatic arthritis	0.00205	0.028	CcSEcCtD
Aminoglutethimide—Hirsutism—Dexamethasone—psoriatic arthritis	0.00186	0.0255	CcSEcCtD
Aminoglutethimide—Hirsutism—Betamethasone—psoriatic arthritis	0.00186	0.0255	CcSEcCtD
Aminoglutethimide—Anaemia—Auranofin—psoriatic arthritis	0.00164	0.0225	CcSEcCtD
Aminoglutethimide—Hirsutism—Prednisone—psoriatic arthritis	0.00162	0.0222	CcSEcCtD
Aminoglutethimide—Leukopenia—Auranofin—psoriatic arthritis	0.00159	0.0218	CcSEcCtD
Aminoglutethimide—Hypothyroidism—Prednisone—psoriatic arthritis	0.00147	0.0201	CcSEcCtD
Aminoglutethimide—Anorexia—Auranofin—psoriatic arthritis	0.00138	0.0189	CcSEcCtD
Aminoglutethimide—Decreased appetite—Auranofin—psoriatic arthritis	0.00126	0.0172	CcSEcCtD
Aminoglutethimide—Urticaria—Auranofin—psoriatic arthritis	0.00115	0.0158	CcSEcCtD
Aminoglutethimide—Pruritus—Auranofin—psoriatic arthritis	0.00103	0.014	CcSEcCtD
Aminoglutethimide—Hepatotoxicity—Methotrexate—psoriatic arthritis	0.00102	0.0139	CcSEcCtD
Aminoglutethimide—Vomiting—Auranofin—psoriatic arthritis	0.000922	0.0126	CcSEcCtD
Aminoglutethimide—Rash—Auranofin—psoriatic arthritis	0.000915	0.0125	CcSEcCtD
Aminoglutethimide—Dermatitis—Auranofin—psoriatic arthritis	0.000914	0.0125	CcSEcCtD
Aminoglutethimide—Nausea—Auranofin—psoriatic arthritis	0.000862	0.0118	CcSEcCtD
Aminoglutethimide—Neutropenia—Prednisone—psoriatic arthritis	0.000553	0.00756	CcSEcCtD
Aminoglutethimide—Pancytopenia—Methotrexate—psoriatic arthritis	0.000469	0.00642	CcSEcCtD
Aminoglutethimide—Neutropenia—Methotrexate—psoriatic arthritis	0.000462	0.00632	CcSEcCtD
Aminoglutethimide—Tachycardia—Prednisolone—psoriatic arthritis	0.000451	0.00617	CcSEcCtD
Aminoglutethimide—Myalgia—Triamcinolone—psoriatic arthritis	0.000444	0.00607	CcSEcCtD
Aminoglutethimide—Myalgia—Methylprednisolone—psoriatic arthritis	0.000443	0.00605	CcSEcCtD
Aminoglutethimide—Drowsiness—Methotrexate—psoriatic arthritis	0.00044	0.00602	CcSEcCtD
Aminoglutethimide—Tachycardia—Triamcinolone—psoriatic arthritis	0.000415	0.00568	CcSEcCtD
Aminoglutethimide—Tachycardia—Methylprednisolone—psoriatic arthritis	0.000414	0.00566	CcSEcCtD
Aminoglutethimide—Agranulocytosis—Methotrexate—psoriatic arthritis	0.000411	0.00562	CcSEcCtD
Aminoglutethimide—Myalgia—Betamethasone—psoriatic arthritis	0.000403	0.00551	CcSEcCtD
Aminoglutethimide—Myalgia—Dexamethasone—psoriatic arthritis	0.000403	0.00551	CcSEcCtD
Aminoglutethimide—Hypotension—Methylprednisolone—psoriatic arthritis	0.000397	0.00542	CcSEcCtD
Aminoglutethimide—Musculoskeletal discomfort—Triamcinolone—psoriatic arthritis	0.000388	0.0053	CcSEcCtD
Aminoglutethimide—Musculoskeletal discomfort—Methylprednisolone—psoriatic arthritis	0.000387	0.00529	CcSEcCtD
Aminoglutethimide—Anaemia—Prednisone—psoriatic arthritis	0.000381	0.00521	CcSEcCtD
Aminoglutethimide—Tachycardia—Dexamethasone—psoriatic arthritis	0.000377	0.00515	CcSEcCtD
Aminoglutethimide—Tachycardia—Betamethasone—psoriatic arthritis	0.000377	0.00515	CcSEcCtD
Aminoglutethimide—Anorexia—Betamethasone—psoriatic arthritis	0.000368	0.00503	CcSEcCtD
Aminoglutethimide—Anorexia—Dexamethasone—psoriatic arthritis	0.000368	0.00503	CcSEcCtD
Aminoglutethimide—Urticaria—Prednisolone—psoriatic arthritis	0.000367	0.00503	CcSEcCtD
Aminoglutethimide—Hypotension—Betamethasone—psoriatic arthritis	0.000361	0.00493	CcSEcCtD
Aminoglutethimide—Hypotension—Dexamethasone—psoriatic arthritis	0.000361	0.00493	CcSEcCtD
Aminoglutethimide—Musculoskeletal discomfort—Dexamethasone—psoriatic arthritis	0.000352	0.00481	CcSEcCtD
Aminoglutethimide—Musculoskeletal discomfort—Betamethasone—psoriatic arthritis	0.000352	0.00481	CcSEcCtD
Aminoglutethimide—Myalgia—Prednisone—psoriatic arthritis	0.000351	0.0048	CcSEcCtD
Aminoglutethimide—Hypersensitivity—Prednisolone—psoriatic arthritis	0.000341	0.00466	CcSEcCtD
Aminoglutethimide—Urticaria—Triamcinolone—psoriatic arthritis	0.000338	0.00462	CcSEcCtD
Aminoglutethimide—Urticaria—Methylprednisolone—psoriatic arthritis	0.000337	0.00461	CcSEcCtD
Aminoglutethimide—Body temperature increased—Triamcinolone—psoriatic arthritis	0.000336	0.0046	CcSEcCtD
Aminoglutethimide—Decreased appetite—Dexamethasone—psoriatic arthritis	0.000336	0.00459	CcSEcCtD
Aminoglutethimide—Decreased appetite—Betamethasone—psoriatic arthritis	0.000336	0.00459	CcSEcCtD
Aminoglutethimide—Tachycardia—Prednisone—psoriatic arthritis	0.000328	0.00449	CcSEcCtD
Aminoglutethimide—Anorexia—Prednisone—psoriatic arthritis	0.00032	0.00438	CcSEcCtD
Aminoglutethimide—Anaemia—Methotrexate—psoriatic arthritis	0.000318	0.00435	CcSEcCtD
Aminoglutethimide—Hypersensitivity—Triamcinolone—psoriatic arthritis	0.000313	0.00429	CcSEcCtD
Aminoglutethimide—Hypersensitivity—Methylprednisolone—psoriatic arthritis	0.000313	0.00428	CcSEcCtD
Aminoglutethimide—Leukopenia—Methotrexate—psoriatic arthritis	0.000308	0.00421	CcSEcCtD
Aminoglutethimide—Urticaria—Betamethasone—psoriatic arthritis	0.000307	0.00419	CcSEcCtD
Aminoglutethimide—Urticaria—Dexamethasone—psoriatic arthritis	0.000307	0.00419	CcSEcCtD
Aminoglutethimide—Musculoskeletal discomfort—Prednisone—psoriatic arthritis	0.000306	0.00419	CcSEcCtD
Aminoglutethimide—Dizziness—Prednisolone—psoriatic arthritis	0.000306	0.00418	CcSEcCtD
Aminoglutethimide—Body temperature increased—Betamethasone—psoriatic arthritis	0.000305	0.00417	CcSEcCtD
Aminoglutethimide—Body temperature increased—Dexamethasone—psoriatic arthritis	0.000305	0.00417	CcSEcCtD
Aminoglutethimide—Pruritus—Triamcinolone—psoriatic arthritis	0.000301	0.00412	CcSEcCtD
Aminoglutethimide—Pruritus—Methylprednisolone—psoriatic arthritis	0.0003	0.00411	CcSEcCtD
Aminoglutethimide—Myalgia—Methotrexate—psoriatic arthritis	0.000293	0.00401	CcSEcCtD
Aminoglutethimide—Decreased appetite—Prednisone—psoriatic arthritis	0.000292	0.004	CcSEcCtD
Aminoglutethimide—Rash—Prednisolone—psoriatic arthritis	0.000292	0.00399	CcSEcCtD
Aminoglutethimide—Dermatitis—Prednisolone—psoriatic arthritis	0.000291	0.00398	CcSEcCtD
Aminoglutethimide—Headache—Prednisolone—psoriatic arthritis	0.00029	0.00396	CcSEcCtD
Aminoglutethimide—Dizziness—Triamcinolone—psoriatic arthritis	0.000281	0.00385	CcSEcCtD
Aminoglutethimide—Dizziness—Methylprednisolone—psoriatic arthritis	0.000281	0.00384	CcSEcCtD
Aminoglutethimide—Nausea—Prednisolone—psoriatic arthritis	0.000275	0.00376	CcSEcCtD
Aminoglutethimide—Pruritus—Dexamethasone—psoriatic arthritis	0.000273	0.00373	CcSEcCtD
Aminoglutethimide—Pruritus—Betamethasone—psoriatic arthritis	0.000273	0.00373	CcSEcCtD
Aminoglutethimide—Vomiting—Triamcinolone—psoriatic arthritis	0.00027	0.0037	CcSEcCtD
Aminoglutethimide—Vomiting—Methylprednisolone—psoriatic arthritis	0.00027	0.00369	CcSEcCtD
Aminoglutethimide—Rash—Triamcinolone—psoriatic arthritis	0.000268	0.00367	CcSEcCtD
Aminoglutethimide—Dermatitis—Triamcinolone—psoriatic arthritis	0.000268	0.00366	CcSEcCtD
Aminoglutethimide—Anorexia—Methotrexate—psoriatic arthritis	0.000268	0.00366	CcSEcCtD
Aminoglutethimide—Rash—Methylprednisolone—psoriatic arthritis	0.000268	0.00366	CcSEcCtD
Aminoglutethimide—Dermatitis—Methylprednisolone—psoriatic arthritis	0.000267	0.00366	CcSEcCtD
Aminoglutethimide—Urticaria—Prednisone—psoriatic arthritis	0.000267	0.00365	CcSEcCtD
Aminoglutethimide—Headache—Triamcinolone—psoriatic arthritis	0.000266	0.00364	CcSEcCtD
Aminoglutethimide—Headache—Methylprednisolone—psoriatic arthritis	0.000266	0.00364	CcSEcCtD
Aminoglutethimide—Body temperature increased—Prednisone—psoriatic arthritis	0.000266	0.00363	CcSEcCtD
Aminoglutethimide—Hypotension—Methotrexate—psoriatic arthritis	0.000262	0.00359	CcSEcCtD
Aminoglutethimide—Musculoskeletal discomfort—Methotrexate—psoriatic arthritis	0.000256	0.0035	CcSEcCtD
Aminoglutethimide—Dizziness—Dexamethasone—psoriatic arthritis	0.000255	0.00349	CcSEcCtD
Aminoglutethimide—Dizziness—Betamethasone—psoriatic arthritis	0.000255	0.00349	CcSEcCtD
Aminoglutethimide—Nausea—Triamcinolone—psoriatic arthritis	0.000253	0.00346	CcSEcCtD
Aminoglutethimide—Nausea—Methylprednisolone—psoriatic arthritis	0.000252	0.00345	CcSEcCtD
Aminoglutethimide—Somnolence—Methotrexate—psoriatic arthritis	0.00025	0.00342	CcSEcCtD
Aminoglutethimide—Hypersensitivity—Prednisone—psoriatic arthritis	0.000248	0.00339	CcSEcCtD
Aminoglutethimide—Vomiting—Dexamethasone—psoriatic arthritis	0.000245	0.00336	CcSEcCtD
Aminoglutethimide—Vomiting—Betamethasone—psoriatic arthritis	0.000245	0.00336	CcSEcCtD
Aminoglutethimide—Decreased appetite—Methotrexate—psoriatic arthritis	0.000244	0.00334	CcSEcCtD
Aminoglutethimide—Rash—Betamethasone—psoriatic arthritis	0.000243	0.00333	CcSEcCtD
Aminoglutethimide—Rash—Dexamethasone—psoriatic arthritis	0.000243	0.00333	CcSEcCtD
Aminoglutethimide—Dermatitis—Betamethasone—psoriatic arthritis	0.000243	0.00332	CcSEcCtD
Aminoglutethimide—Dermatitis—Dexamethasone—psoriatic arthritis	0.000243	0.00332	CcSEcCtD
Aminoglutethimide—Headache—Betamethasone—psoriatic arthritis	0.000242	0.00331	CcSEcCtD
Aminoglutethimide—Headache—Dexamethasone—psoriatic arthritis	0.000242	0.00331	CcSEcCtD
Aminoglutethimide—Pruritus—Prednisone—psoriatic arthritis	0.000238	0.00325	CcSEcCtD
Aminoglutethimide—Nausea—Betamethasone—psoriatic arthritis	0.000229	0.00314	CcSEcCtD
Aminoglutethimide—Nausea—Dexamethasone—psoriatic arthritis	0.000229	0.00314	CcSEcCtD
Aminoglutethimide—Urticaria—Methotrexate—psoriatic arthritis	0.000223	0.00305	CcSEcCtD
Aminoglutethimide—Dizziness—Prednisone—psoriatic arthritis	0.000222	0.00304	CcSEcCtD
Aminoglutethimide—Body temperature increased—Methotrexate—psoriatic arthritis	0.000222	0.00304	CcSEcCtD
Aminoglutethimide—Vomiting—Prednisone—psoriatic arthritis	0.000214	0.00292	CcSEcCtD
Aminoglutethimide—Rash—Prednisone—psoriatic arthritis	0.000212	0.0029	CcSEcCtD
Aminoglutethimide—Dermatitis—Prednisone—psoriatic arthritis	0.000212	0.0029	CcSEcCtD
Aminoglutethimide—Headache—Prednisone—psoriatic arthritis	0.000211	0.00288	CcSEcCtD
Aminoglutethimide—Hypersensitivity—Methotrexate—psoriatic arthritis	0.000207	0.00283	CcSEcCtD
Aminoglutethimide—Nausea—Prednisone—psoriatic arthritis	0.0002	0.00273	CcSEcCtD
Aminoglutethimide—Pruritus—Methotrexate—psoriatic arthritis	0.000199	0.00272	CcSEcCtD
Aminoglutethimide—Dizziness—Methotrexate—psoriatic arthritis	0.000186	0.00254	CcSEcCtD
Aminoglutethimide—Vomiting—Methotrexate—psoriatic arthritis	0.000179	0.00244	CcSEcCtD
Aminoglutethimide—Rash—Methotrexate—psoriatic arthritis	0.000177	0.00242	CcSEcCtD
Aminoglutethimide—Dermatitis—Methotrexate—psoriatic arthritis	0.000177	0.00242	CcSEcCtD
Aminoglutethimide—Headache—Methotrexate—psoriatic arthritis	0.000176	0.00241	CcSEcCtD
Aminoglutethimide—Nausea—Methotrexate—psoriatic arthritis	0.000167	0.00228	CcSEcCtD
